Table I.
Gender (N, %) | |
Male | 15 (14.3%) |
Female | 90 (85.7%) |
Age at visit (years) (Avg±SD) | 45.7±13.2 |
19–30 years (N, %) | 14 (13.3%) |
31–40 years | 25 (23.8%) |
41–50 years | 28 (26.7%) |
51–60 years | 24 (22.9%) |
61+ years | 14 (13.3%) |
Ethnicity (N, %) | |
African-American | 54 (51.4%) |
Caucasian | 37 (35.2%) |
Hispanic | 8 (7.6%) |
Asian | 4 (3.8%) |
Mixed | 2 (1.9%) |
Educational level* (N, %) | |
High school or less | 43 (48.3%) |
College or equivalent | 36 (40.4%) |
Graduate school or higher | 10 (11.2%) |
Income (yearly)* (N, %) | |
Less than $10,000 | 37 (37.4%) |
$10,000 – $50,000 | 37 (37.4%) |
$50,000 – $100,000 | 19 (19.2%) |
More than $100,000 | 6 (6.1%) |
Fitzpatrick skin type* (N, %) | |
I–II | 22 (22.2%) |
III–IV | 33 (33.3%) |
V–VI | 44 (44.4%) |
Season of visit (N,%) | |
Spring | 21 (20.0%) |
Summer | 36 (34.3%) |
Fall | 23 (21.9%) |
Winter | 25 (23.8%) |
Disease duration (years)* (Avg±SD) | 8.1±8.2 |
CLE subtype* (N, %) | |
ACLE | 11 (10.6%) |
SCLE | 18 (17.3%) |
DLE | 70 (67.3%) |
Chilblains lupus | 3 (2.9%) |
Tumid lupus | 2 (1.9%) |
Number of SLE criteria met (Avg±SD) | 4.5±2.1 |
SLE diagnosis? (N, %) | |
Yes | 63 (60.0%) |
No | 42 (40.0%) |
CLASI activity score (Avg±SD) | 5.2±5.4 |
CLASI damage score (Avg±SD) | 6.7±6.9 |
SLEDAI score (Avg±SD) | 1.9±2.5 |
Number of oral lupus medications (Avg±SD) | 1.3±1.1 |
Time spent in sun (hrs/wk)* (N, %) | |
<2 | 53 (53.0%) |
2–4 | 23 (23.0%) |
4–6 | 6 (6.0%) |
>6 | 18 (18.0%) |
Work outdoors for occupation?* (N, %) | |
Yes | 12 (12.1%) |
No | 87 (87.9%) |
History of photosensitivity (N, %) | |
Yes | 87 (82.9%) |
No | 18 (17.1%) |
History of smoking* (N, %) | |
Never | 52 (50.0%) |
Past | 16 (15.4%) |
Current | 36 (34.6%) |
Information on specific patient characteristics were not available for the following: education (16 unavailable), income (6 unavailable), Fitzpatrick skin type (6 unavailable), disease duration (2 unavailable), CLE subtype (1 unavailable), time spent in sun (5 unavailable), work outdoors (6 unavailable), and history of smoking (1 unavailable).
Abbreviations: ACLE = acute cutaneous lupus erythematosus; CLE = cutaneous lupus erythematosus; DLE = discoid lupus erythematosus; SCLE = subacute cutaneous lupus erythematosus; SLE = systemic lupus erythematosus